- Global Pharma News & Resources

PTC Therapeutics to Participate at Upcoming Investor Conference

PTC Therapeutics to Participate at Upcoming Investor Conference

PR Newswire

SOUTH PLAINFIELD, N.J., Oct. 30, 2018

SOUTH PLAINFIELD, N.J., Oct. 30, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13th at 10:55 a.m. MST.  

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at and will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Investor Presentation is available at the same website location.

About PTC Therapeutics, Inc.
PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Founded 20 years ago, PTC Therapeutics has successfully launched two rare disorder products and has a global commercial footprint. This success is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.




Jane Baj    

Emily Hill

+1 (908) 912-9167  

+1 (908) 912-9327


View original content:

SOURCE PTC Therapeutics, Inc.

Editor Details

Last Updated: 30-Oct-2018